Immuno-Oncology Clinical Trials Market - Global Industry Analysis
Immuno-Oncology Clinical Trials Market- By Design (Interventional Trials and Observational Trials), By Phase (Phase I, Phase II, Phase III, and Phase IV), By Indication (Solid Tumors and Hematological Cancer), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028
Published Date: 08-Nov-2021Healthcare
Category: Report Format : PDF
Report Code: ZMR-6815
Status : Published
The global Immuno-Oncology Clinical Trials Market accrued earnings worth approximately 5.4 (USD Billion) in 2020 and is predicted to gain revenue of about 15.6 (USD Billion) by 2028, is set to record a CAGR of nearly 13.7% over the period from 2021 to 2028.